EDGEWELL PERSONAL CARE EPC
- Market cap
- $1.3B
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.6×
- EV/EBIT
- 17.9×
- Revenue, 12 months
- $2B
- +2% on a year ago
- Net margin
- −4.5%
- Free cash flow yield
- 4.1%
EDGEWELL PERSONAL CARE trades at 0.6× sales. Its trailing earnings are negative, so it has no PE. Revenue was $2B over the last twelve months, up 2% on a year earlier with a −5% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $534.1M−1% | $488.9M+4% | $599.4M+0% | $647.8M−0% | $517.6M−3% | $415.1M−15% | $516.6M−14% | $560.4M−14% | $537.2M+4% | $422.8M+2% | $519.5M+1% | $570.1M+2% | |
| Cost of revenue | $305.5M−4% | $291.2M+4% | $341.3M−4% | $360.7M−2% | $304.8M−0% | $242.6M−17% | $279.7M−18% | $310.3M−14% | $328.6M+8% | $261.8M+8% | $302.6M+8% | $327.6M+6% |
| Gross profit | $228.6M+4% | $197.7M+4% | $258.1M+7% | $287.1M+2% | $212.8M−7% | $172.5M−13% | $236.9M−8% | $250.1M−13% | $208.6M−2% | $161M−7% | $216.9M−8% | $242.5M−3% |
| R&D | $15.9M+3% | $13.3M−1% | $14.2M−1% | $14.6M−1% | $16.3M+3% | $13.4M+1% | $13.4M−6% | $13.5M−8% | $15.8M−3% | $13.8M+3% | $14.9M+11% | $13.3M−2% |
| SG&A | $112.4M+15% | $103.3M+8% | $107.5M+2% | $110.1M+14% | $109.2M−3% | $99.6M−4% | $102.8M−4% | $100.7M−9% | $112M+3% | $102.4M+3% | $111M+8% | $108.3M+8% |
| $52.1M−12% | $26.1M−18% | $70.1M+23% | $82.7M−4% | $20.4M−61% | $9.3M−64% | $49M−30% | $45M−46% | −$36.3M | −$18.9M | $18.4M−62% | $25M−44% | |
| Interest expense | $18.7M+3% | $19.8M−1% | $20.4M−1% | $18.8M−2% | $17.5M−6% | $18.8M−5% | $20.2M−1% | $19.4M+3% | $14.8M−15% | $19.3M+3% | $17.9M−11% | $16.7M−14% |
| Pre-tax income | $33.3M−25% | $6M−65% | $47M+77% | $62.5M−12% | $5.4M−84% | −$12.7M | $31.4M−33% | $28.5M−54% | −$53.2M | −$36.9M+191% | $7.9M−75% | $18M−37% |
| $3.4M−66% | $1.2M−74% | $11M+53% | $13.5M−24% | −$3.4M | −$2.6M | $10.6M−4% | $7M−48% | −$22.6M+565% | −$7.7M+196% | $3.9M−63% | $5.7M−19% | |
| Net income | $29.9M−11% | $4.8M−61% | $36M+86% | $49M−8% | $8.8M−71% | −$2.1M | $29M−19% | $29.1M−41% | −$30.6M | −$65.7M+3029% | −$10.6M | $13.7M−53% |
| $0.58−11% | $0.09−63% | $0.72+95% | $0.98−4% | $0.18−69% | −$0.04 | $0.60−17% | $0.62−37% | −$0.66 | −$1.41+3425% | −$0.22 | $0.29−53% | |
| 51.5M−1% | 50.5M−3% | 50.2M−4% | 50.1M−3% | 49.5M−4% | 48.7M−4% | 48.2M−4% | 47M−6% | 46.6M−6% | 46.6M−4% | 46.8M−3% | 46.6M−1% |
Operating income: 19 periods, Q1 FY10 to Q4 FY14: not printed by the filing, worked out from its own lines.
EPS, diluted: 9 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY10 and Q2 FY10: not printed by the filing, worked out from its own lines. 13 periods, Q4 FY10 to Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days. 3 periods, Q4 FY15 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Household & Personal Products nearest EDGEWELL PERSONAL CARE's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| EPCEDGEWELL PERSONAL CARE | $1.3B | n/m | 20.3× | 0.6× | +2% | −4.5% | |
| IPARInterparfums | $3.7B | 22.0× | 30.4× | 2.5× | +3% | 11.2% | |
| REYNReynolds Consumer Products | $4.9B | 14.0× | 17.6× | 1.3× | +3% | 9.1% | |
| ELFe.l.f. Beauty | $6.7B | 114× | 69.2× | 3.8× | +31% | 3.4% | |
| Peer median | $4.9B | 22.0× | 30.4× | 2.5× | +3% | 9.1% |
Investors who own it
Investors we follow who held EDGEWELL PERSONAL CARE at the end of Jun 30, 2026, from their 13F filings.
- Lee AinslieMaverick Capital0.0% of portfoliotrimmed
More on EDGEWELL PERSONAL CARE
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #4of 19Household and personal products stocks with the lowest price to sales ratio
- #8of 15Household and personal products stocks with the lowest EV/EBIT
Its groups
About
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
Valuation data, not investment advice. Prices as of .